Ani Pharmaceuticals Stock Analysis

ANI Stock Analysis Notes

About 90.0% of the company shares are held by institutions such as insurance companies. The book value of ANI Pharmaceuticals was presently reported as 24.19. The company has Price/Earnings To Growth (PEG) ratio of 1.06. ANI Pharmaceuticals had not issued any dividends in recent years. The entity had 1:6 split on the 18th of July 2013. ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota. ANI Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 601 people. For more info on ANI Pharmaceuticals please contact Nikhil Lalwani at 218 634 3500 or go to https://www.anipharmaceuticals.com.

ANI Pharmaceuticals Investment Alerts

ANI Largest EPS Surprises

View All Earnings Estimates

ANI Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

ANI Stock Institutional Investors

Note, although ANI Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ANI Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.75 B.

ANI Profitablity

The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1.

Management Efficiency

ANI Pharmaceuticals has return on total asset (ROA) of 0.0237 % which means that it generated a profit of $0.0237 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0866 %, meaning that it created $0.0866 on every $100 dollars invested by stockholders. ANI Pharmaceuticals' management efficiency ratios could be used to measure how well ANI Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/21/2026, Return On Capital Employed is likely to grow to 0.0005, while Return On Tangible Assets are likely to drop (0.03). At this time, ANI Pharmaceuticals' Total Current Liabilities is relatively stable compared to the past year. As of 02/21/2026, Liabilities And Stockholders Equity is likely to grow to about 1.6 B, while Non Current Liabilities Other is likely to drop slightly above 16.1 M.

Technical Drivers

As of the 21st of February, ANI Pharmaceuticals shows the Coefficient Of Variation of (2,312), mean deviation of 1.45, and Risk Adjusted Performance of (0.03). ANI Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

ANI Pharmaceuticals Price Movement Analysis

ANI Pharmaceuticals Insider Trading Activities

ANI Pharmaceuticals Outstanding Bonds

ANI Pharmaceuticals Predictive Daily Indicators

ANI Pharmaceuticals Corporate Filings

ANI Pharmaceuticals Forecast Models

ANI Pharmaceuticals' time-series forecasting models are one of many ANI Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ANI Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

ANI Pharmaceuticals Bond Ratings

ANI Pharmaceuticals financial ratings play a critical role in determining how much ANI Pharmaceuticals have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for ANI Pharmaceuticals' borrowing costs.

ANI Pharmaceuticals Debt to Cash Allocation

ANI Pharmaceuticals currently holds 624.09 M in liabilities with Debt to Equity (D/E) ratio of 0.86, which is about average as compared to similar companies. ANI Pharmaceuticals has a current ratio of 3.28, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ANI Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.

ANI Pharmaceuticals Total Assets Over Time

ANI Pharmaceuticals Assets Financed by Debt

The debt-to-assets ratio shows the degree to which ANI Pharmaceuticals uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

ANI Pharmaceuticals Debt Ratio

30.0

It seems slightly above 70% of ANI Pharmaceuticals' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the ANI Pharmaceuticals' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of ANI Pharmaceuticals, which in turn will lower the firm's financial flexibility.

ANI Pharmaceuticals Corporate Bonds Issued

ANI Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how ANI Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ANI shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ANI Pharmaceuticals. By using and applying ANI Stock analysis, traders can create a robust methodology for identifying ANI entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ANI analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ANI analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

ANI Pharmaceuticals stock analysis indicators help investors evaluate how ANI Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ANI Pharmaceuticals shares will generate the highest return on investment. By understating and applying ANI Pharmaceuticals stock analysis, traders can identify ANI Pharmaceuticals position entry and exit signals to maximize returns.

When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.